Why Cancer-Fighting Stocks a ETFs Are Soaring
The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast. (1:00) - What Can Investors Learn From the ASCO Annual Meeting? (5:45) - What Is Immunotherapy and What Are The Benefits? (12:15) - What Companies Are Leading The Way? (17:50) - AstraZeneca's Early Stage Cancer Treatments (21:00) - Recent Merger and Acquisitions For Biopharmaceutical Industry (23:25) - Loncar Cancer Immunotherapy ETF: CNCR (26:40) - Policy Concerns Impacting The Healthcare Sector Podcast@Zacks.com
